RenovoRx (RNXT) Competitors $1.40 +0.12 (+8.95%) Closing price 04:00 PM EasternExtended Trading$1.39 -0.01 (-0.71%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNXT vs. ALMS, OGI, DRUG, LFVN, NLTX, GNFT, IMAB, CYBN, VYGR, and PBYIShould you be buying RenovoRx stock or one of its competitors? The main competitors of RenovoRx include Alumis (ALMS), Organigram Global (OGI), Bright Minds Biosciences (DRUG), Lifevantage (LFVN), Neoleukin Therapeutics (NLTX), GENFIT (GNFT), I-Mab (IMAB), Cybin (CYBN), Voyager Therapeutics (VYGR), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical products" industry. RenovoRx vs. Its Competitors Alumis Organigram Global Bright Minds Biosciences Lifevantage Neoleukin Therapeutics GENFIT I-Mab Cybin Voyager Therapeutics Puma Biotechnology Alumis (NASDAQ:ALMS) and RenovoRx (NASDAQ:RNXT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations. Does the media refer more to ALMS or RNXT? In the previous week, Alumis and Alumis both had 2 articles in the media. Alumis' average media sentiment score of 1.89 equaled RenovoRx'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alumis 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive RenovoRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts recommend ALMS or RNXT? Alumis currently has a consensus target price of $22.86, indicating a potential upside of 534.92%. RenovoRx has a consensus target price of $7.25, indicating a potential upside of 417.86%. Given Alumis' stronger consensus rating and higher probable upside, research analysts plainly believe Alumis is more favorable than RenovoRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alumis 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22RenovoRx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, ALMS or RNXT? RenovoRx has higher revenue and earnings than Alumis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlumisN/AN/A-$294.23MN/AN/ARenovoRx$240K213.34-$8.81M-$0.40-3.50 Do insiders & institutionals believe in ALMS or RNXT? 3.1% of RenovoRx shares are owned by institutional investors. 40.7% of Alumis shares are owned by company insiders. Comparatively, 9.1% of RenovoRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is ALMS or RNXT more profitable? RenovoRx's return on equity of -119.58% beat Alumis' return on equity.Company Net Margins Return on Equity Return on Assets AlumisN/A -406.27% -107.29% RenovoRx N/A -119.58%-88.01% SummaryAlumis and RenovoRx tied by winning 5 of the 10 factors compared between the two stocks. Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RNXT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RNXT vs. The Competition Export to ExcelMetricRenovoRxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.20M$2.95B$5.53B$9.13BDividend YieldN/A2.43%5.06%4.01%P/E Ratio-3.5021.1628.5819.57Price / Sales213.34184.61372.6479.65Price / CashN/A41.0524.7227.51Price / Book7.377.748.235.56Net Income-$8.81M-$55.05M$3.19B$252.37M7 Day Performance6.06%12.77%5.46%3.11%1 Month Performance7.69%13.59%9.39%11.74%1 Year Performance8.42%4.43%30.48%17.41% RenovoRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RNXTRenovoRx2.5835 of 5 stars$1.40+8.9%$7.25+417.9%-0.5%$51.20M$240K-3.506News CoveragePositive NewsALMSAlumis3.595 of 5 stars$3.46+4.5%$22.86+560.6%-68.3%$188.26MN/A0.00N/ANews CoverageOGIOrganigram Global1.1571 of 5 stars$1.41+1.1%N/A-14.5%$188.19M$117.47M14.05860DRUGBright Minds Biosciences1.9883 of 5 stars$26.50-3.0%$83.25+214.2%+2,477.7%$186.67MN/A-73.61N/ALFVNLifevantage4.3295 of 5 stars$14.57+7.2%$30.50+109.3%+96.7%$183.44M$200.16M21.12260NLTXNeoleukin TherapeuticsN/A$19.50-2.9%N/A-49.7%$183.26MN/A-6.2790High Trading VolumeGNFTGENFIT2.3266 of 5 stars$3.60-1.6%$13.00+261.1%-14.1%$180M$76.77M0.00120Gap UpIMABI-Mab2.8887 of 5 stars$2.20+5.3%$6.00+172.7%+23.8%$179.65M$3.89M0.00380Analyst UpgradeCYBNCybin2.5113 of 5 stars$7.71-2.0%$86.00+1,015.4%N/A$177.52MN/A-1.7650VYGRVoyager Therapeutics3.978 of 5 stars$3.17+4.3%$13.39+322.4%-60.2%$175.43M$80M-2.17100PBYIPuma Biotechnology4.2391 of 5 stars$3.53-0.3%$7.00+98.3%-5.6%$175.19M$230.50M4.58200 Related Companies and Tools Related Companies ALMS Alternatives OGI Alternatives DRUG Alternatives LFVN Alternatives NLTX Alternatives GNFT Alternatives IMAB Alternatives CYBN Alternatives VYGR Alternatives PBYI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RNXT) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNXT Stock Alerts